Pharma & Biotech

A California jury has delivered a significant legal blow to Johnson & Johnson, ordering the healthcare giant to pay $40...

After a period of significant volatility, shares of X4 Pharmaceuticals may be entering a phase of consolidation. The stock closed...

Investors in Neximmune are facing the prospect of an exceptionally turbulent trading session. Market analysis indicates the biotechnology firm's stock...

Shares of Aadi Bioscience have demonstrated stability as the biotechnology firm executes a fundamental strategic overhaul. The company is shifting...

A prominent financial publication's recent endorsement has refocused investor attention on Viking Therapeutics and its potential trajectory through 2026. The...

Shares of ophthalmic medical technology company Glaukos are receiving conflicting cues from the market. While prominent Wall Street analysts are...

While BioNTech stock trades near its 52-week low, a significant shift is occurring behind the scenes. Prominent institutional investors are...

For remaining investors in CureVac, the clock is ticking down to a decisive moment. The company's journey as an independent...

Immunovant Inc. has received a significant financial boost, with its shares trading notably higher following the successful completion of a...

The outlook for UnitedHealth Group is becoming increasingly complex as the healthcare giant contends with dual challenges: a significant new...